ITEM 1A. RISK FACTORS   There have been no material changes in AbbVie’s risk factors from those disclosed in the company’s Annual Report on Form 10-K for the year ended December 31, 2013, except for the following:   The proposed combination of AbbVie and Shire plc may not be completed on the currently contemplated timeline or terms, or at all, and may not achieve the intended benefits.   Consummation of the combination of AbbVie and Shire plc is conditioned on, among other things, obtaining necessary governmental, regulatory, and stockholder approvals. If any of the conditions to the combination is not satisfied, it could delay or prevent the proposed combination from occurring, which could negatively impact AbbVie’s share price and future business and financial results. In addition, legal, investment banking, acquisition financing, and potential termination fees and expenses related to the proposed acquisition are significant and could adversely affect AbbVie’s financial position and results of operations. Following the proposed combination, AbbVie may not realize the proposed combination’s intended benefits.   33      Table of Contents   ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS